Share on Pinterest An SGLT-2 inhibitor drug plus a moderately calorie-restrictive diet may be the best approach for achieving diabetes remission. Image credit: Xvision/Getty Images. About 828 ...

Dapagliflozin is a sodium glucose co-transporter 2 (SGLT2) inhibitor. It helps treat diabetes by preventing blood sugar from being absorbed in the kidneys; instead, excess glucose is excreted in ...

The growing elderly population is more susceptible to type 2 diabetes fuels the need for SGLT2 inhibitors in Asia Pacific. • The market segmentation is primarily based on indication, drug, ...

The SGLT2 inhibitors, as a class, lead to similar treatment benefits at comparable clinical doses, although there are some discrepancies between them, particularly when dapagliflozin (Farxiga; ...

Opens in a new tab or window Comparative effectiveness study followed adults with type 2 diabetes who initiated SGLT-2 inhibitors from 2014 to 2020. Real-world outcomes largely point to comparable ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much ...

Channel 2 Action News got an exclusive look at a new Watershed Command Center. Channel 2 Action News followed the City of Atlanta Watershed employees’ stock up and head out as they repaired ...

SGLT2 inhibitor use might be renoprotective in patients with ADPKD, but could increase kidney volume. Dapagliflozin might help protect kidney function in patients with autosomal dominant polycystic ...

Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...